MD2-IN-1
CAS No. 111797-22-9
MD2-IN-1 ( MD2-IN-1; MDK7229; MDK 7229; MDK 7229. )
Catalog No. M17145 CAS No. 111797-22-9
MD2-IN-1 is an inhibitor of Myeloid differentiation protein 2 (MD2) with a KD of 189 μM for the recombinant human MD2 (rhMD2).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 161 | In Stock |
|
10MG | 266 | In Stock |
|
25MG | 478 | In Stock |
|
50MG | 691 | In Stock |
|
100MG | 963 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMD2-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionMD2-IN-1 is an inhibitor of Myeloid differentiation protein 2 (MD2) with a KD of 189 μM for the recombinant human MD2 (rhMD2).
-
DescriptionMDK7229, also known as MD2-IN-1 is a MD2 (Myeloid differentiation protein 2) inhibitor. MDK7229 has CAS#111797-22-9. For easy communication, we use its last 4 digit of CAS for name. MDK7229 locked the LPS-induced activation of TLR4/MD2 -downstream pro-inflammatory MAPKs/NF-κB signaling pathways. In a rat model with ALI induced by intracheal LPS instillation, administration MDK7229 exhibited significant protective effect against ALI, accompanied by the inhibition of TLR4/MD2 complex formation in lung tissues.
-
SynonymsMD2-IN-1; MDK7229; MDK 7229; MDK 7229.
-
PathwayOthers
-
TargetOther Targets
-
RecptorMyeloid differentiation protein 2(MD2)
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number111797-22-9
-
Formula Weight358.39
-
Molecular FormulaC20H22O6
-
Purity98%
-
SolubilityDMSO : 50 mg/mL 139.51 mM; H2O : < 0.1 mg/mL
-
SMILESCOc1ccc(cc1OC)C(=O)\C=C\c1cc(OC)c(OC)c(OC)c1
-
Chemical Name(E)-1-(3,4-dimethoxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang Y, et al. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury. Sci Rep. 2016 Apr 27;6:25130.
molnova catalog
related products
-
Ertugliflozin L-pyro...
Ertugliflozin L-pyroglutamic acid is a selective and orally active hSGLT2 inhibitor with an IC50 of 0.877 nM.
-
Furimazine
Furimazine is an imidazopyrazinone substrate. NanoLuc (Nluc) paired with Furimazine produced 2.5 million-fold brighter luminescence in mammalian cells relative to Oluc-19 with Coelenterazine.
-
RI-STAD 2
AKAP disruptor. Selectively binds PKA-RI with high affinity (KD values are 6.2 and 12.1 nM for the RIα and β subunits, respectively) and blocks its interaction with AKAP. Inhibits type I PKA-mediated phosphorylation in live cells. Cell permeable.